If your product is using CentOS Linux 7, you need to migrate to a new operating system by the official end-of-life (EOL) date on June 30, 2024 to ensure ongoing access to security updates, patches, and new features. Good news for CentOS 7 users is that MontaVista has decided to extend the operational life of CentOS 7.9, offering sustained security updates and technical support through our MVShield support program. As a customer of MVShield, you get peace of mind with Enterprise Linux with robust updates for Common Vulnerabilities and Exposures (CVEs) and bug fixes thoroughly validated through our QA test infrastructure.
MONTAVISTA’S CGX 5.0 IS NOW AVAILABLE FOR EARLY ACCESS!Introducing CGX 5.0, the next generation of MontaVista’s Carrier Grade eXpress (CGX) Linux. Based on Linux 6.6 LTS kernel and Yocto 5.0, CGX 5.0 provides a professionally supported Linux distribution designed for developing a broad range of embedded applications across industries. CGX 5.0 is our first release with AI readiness and new security features based on Secure By Design principles, CVE and SBOM management, aligning with industry best practices for software supply chain security. CGX 5.0 is available for immediate early access, with general availability projected for Q4.
MONTAVISTA’S SOLUTION TO FDA SECURITY REQUIREMENTS FOR MEDICAL DEVICESThe U.S. Food and Drug Administration (FDA) actively provides guidelines and recommendations to manufacturers to ensure the security of medical devices, especially those with embedded software. Through our suite of offerings - MontaVista’s CGX, MVShield, and MVSecure, MontaVista delivers a robust security framework tailored to the unique needs of the medical market. We empower medical technology developers to proactively address software security threats and vulnerabilities, including those identified through CVEs, providing compliance with FDA regulations and enhanced overall device security.
You’ve received this issue of MontaVista’s newsletter because you agreed to receive marketing communication from us. We hope you choose to receive more news in the future, but you can unsubscribe at any time.
